Company / SG&A per Share
Cartesian Therapeutics, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.17
FY2025
5-year range
$0.14 / $7.49
FY2021-FY2025
Trend
-84.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 8 years, ranging from $0.14 in FY2023 to $7.49 in FY2024.
Based on SEC 10-K filings.
1.17 in FY2025 with a 5-year CAGR of +40.8%.
Increased from $0.14 to $1.17 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +97.0%
- 5-Year CAGR
- +40.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 84.4% year-over-year.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.17 | -84.4% |
| FY2024 | $7.49 | +5377.7% |
| FY2023 | $0.14 | -10.6% |
| FY2022 | $0.15 | +0.9% |
| FY2021 | $0.15 | -28.2% |
| FY2020 | $0.21 | -74.8% |
| FY2019 | $0.84 | -77.1% |
| FY2016 | $3.66 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026